Anil Rajpal, MD, MPH

US Food and Drug Administration, United States

Anthem, Inc. (Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

• Estimating Real-world Outcomes Under a Rapidly Evolving Treatment Paradigm: Dexamethasone and Inpatient Mortality Among US Hospitalized COVID-19 Patients

  Friday, August 26, 2022
  5:30 PM – 5:45 PM CEST